Membrane Transporter/Ion Channel


Membrane Transporters mediate the movement of ions and molecules via binding and moving the substance across the membrane. There are two main actions of transporter: facilitated diffusion (passive transport) and active transport. Membrane transporters which bind the hydrolysis of ATP to the transport of target molecules are referred to as ATPases. For instance, Na+,K+-ATPases or Na+,K+-pumps are responsible for the transport of Na+ out of and K+ into cells.
Ion channels are pore-forming membrane proteins which allow the flow of ions across the membrane. The ion channels can be broadly grouped into six families including calcium channels, chloride channels, potassium channels, sodium channels, gap junction proteins and porins. Not all ion channels are gated, such as certain type of K+ and Cl– channels, transient receptor potential superfamily of cation channels, the ryanodine receptors and the IP3 receptors, but most Na+, K+, Ca2+ and some Cl– channels are all gated by voltage. Ligand-gated channels are regulated in response to ligand binding (e.g. neurotransmitters signaling). These ligand-gated neurotransmitter receptors are known as ionotropic receptors. Various neurotransmitters couple to ionotropic receptors such as glutamate, acetylcholine, glycine, GABA, and serotonin.
-
B7722 MaxiPostSummary: Potassium channel modulator -
B7751 GSK 2193874Summary: TRPV4 antagonist, potent and selective -
B5084 DL-TBOASummary: inhibitor of excitatory amino acid transporters -
B5086 CGP 55845 hydrochlorideTarget: GABAB ReceptorsSummary: GABAB receptor antagonist -
B5177 OMDM-2Summary: Metabolically stable inhibitor of anandamide cellular uptake -
B5245 6-IodonordihydrocapsaicinSummary: Vanilloid receptor antagonist -
B5286 MNI-caged-D-aspartateSummary: Agonist at NMDA receptors and EAAT substrate -
B5288 DNQX disodium saltSummary: Selective non-NMDA receptor antagonist -
B5312 PPDASummary: Subtype-selective NMDA receptor antagonist -
B5313 TFB-TBOASummary: glial glutamate transporter EAAT1 and EAAT2 inhibitor

